Benesch is pleased to announce that Amy C. Livingston has joined the firm as an associate in the Corporate & Securities Practice Group.
Amy focuses her practice on counseling private equity clients and their portfolio companies in connection with mergers, securities purchases, asset purchases and other acquisitions and investments. Amy also provides ongoing support for portfolio companies with regard to general corporate governance matters, including preparing materials for and participating in board of director meetings, drafting dividend, distribution and contribution agreements, and drafting investment, option and other equity grant agreements.
Amy received her J.D., magna cum laude, from The University of Michigan Law School in 2012 and her B.A. in French and English, with honors, from Grinnell College in 2009.
Latest News
Benesch Government Relations Partner Holly Gross Named a 2026 Women of Influence by Columbus Business First
Benesch is pleased to announce that Government Relations Partner Holly Gross has been named among Columbus Business First’s 2026 Women of Influence in the Trailblazer category. This recognition honors women who are pioneers or firsts in their field and who have broken new ground, opened doors for others or led innovation in industries where women may be underrepresented.
Benesch Represents Tribeca Strategic Acquisition Corporation in $140 Million Public Offering
Benesch represented Tribeca Strategic Acquisition Corporation (Nasdaq: BIDWU) in its $140 million initial public offering on the Nasdaq Global Market. …
Benesch Named Recipient of AHLA 2026 Top Honors for Sixth Consecutive Year
Benesch is pleased to announce that it has been named a recipient of the American Health Law Association’s (AHLA) 2026 …
Daily Journal Names Benesch Partner Charan Brahma a 2026 Top Intellectual Property Lawyer
Benesch is pleased to announce that Intellectual Property Partner Charan Brahma has been named to the Daily Journal’s 2026 Top Intellectual Property Lawyers list. Charan focuses his practice on patent litigation and a range of intellectual property matters, primarily representing pharmaceutical and technology clients. With a strong trial focus, he works closely with clients to develop efficient litigation strategies aligned with their business objectives.